Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Kidney Stone Management Market Report and Forecast 2024-2032" report has…
…
mazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction are part of the Zacks top Analyst Blog.…
Todays Research Daily features new research reports on 12 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson (JNJ) and…
Boston Scientific konnte im dritten Quartal 2024 die Erwartungen der Analysten übertreffen. Der Medizintechnikkonzern erwirtschaftete einen Gewinn von 469 Millionen…
…
Boston Scientific raises annual earnings forecast, shares rise…
Boston Scientific registers year-over-year improvement in sales, indicating solid market share gains in legacy businesses despite macroeconomic odds.…
BSX receives FDA approval for the FARAWAVE NAV Ablation Catheter and FARAVIEW Software, enhancing cardiac mapping and ablation workflows for…
Boston Scientific stock down as Needham cuts to Hold on growth concerns…
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.…
Royal Caribbean Cruises, Boston Scientific and Monolithic Power Systems have been selected as the top picks with a high net…
Investors remain optimistic about Boston Scientific due to its geographical expansions and impressive MedSurg market share gain.…
Boston Scientific achieves PMDA approval for its FARAPULSE PFA System in Japan. The company expects to launch the system in…
S&P 500 stocks such as General Motors, Boston Scientific, and Assurant have been selected as the momentum picks for the…
S&P 500 stocks such as NVIDIA, Boston Scientific and American Water Works are, currently, exhibiting superb earnings growth.…
Boston Scientific received FDA approval on the expanded indication for INGEVITY+ Pacing Leads. Data demonstrated this lead to be safe…
BSX achieves CE Mark approval for the ACURATE Prime Aortic Valve System, its latest TAVR technology.…
ServiceNow (NOW), Boston Scientific (BSX) and The Cooper Companies (COO) have been selected as the top picks with a high…
Boston Scientific (BSX) withdraws its premerger notification and report form to give the U.S. FTC more time to review the…
Amazon, Boston Scientific, Shopify and Cooper-Standard are included in this Analyst Blog.…
Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to ones portfolio. Wall Street analysts overly…
Boston Scientifics (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and…
Boston Scientific (BSX) registers a strong year-over-year improvement in sales, indicating solid market share gains in legacy businesses across all…
In EMEA, Boston Scientific (BSX) is successfully expanding its base, banking on its diverse portfolio, new launches and commercial execution…
…
In EMEA, Boston Scientific (BSX) is expected to have registered growth within structural heart, including Transcatheter aortic valve replacement, WATCHMAN…
Boston Scientific (BSX) secures CE Mark for the DBS image-guided programming software, Vercise Neural Navigator 5.…
Boston Scientific, ResMed, Lantheus and Haemonetics are part of the Zacks Industry Outlook article.…
…
This acquisition is expected to enhance Boston Scientifics (BSX) market position and revenue streams in North America and Europe.…
Silk Road Medical to be acquired by Boston Scientific, shares surge 24%…
…
Boston Scientific to buy Silk Road Medical in $1.16 billion deal…
Boston Scientific to acquire Silk Road Medical for $27.50 per share in cash…
…
Der Kurs der der Aktie von Boston Scientific kommt kaum von der Stelle. Das Wertpapier kostete zuletzt 74,83 US-Dollar. Kaum…
Investors continue to be optimistic about Boston Scientific (BSX) due to its geographical expansions and impressive acquisitions.…
Boston Scientifics (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and…
Investors are optimistic about Boston Scientifics (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.…
Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.…
…
Within Neuromodulation, Boston Scientifics pain business is consistently gaining traction, banking on strength in the spinal cord stimulation (SCS) business.…
Todays Research Daily features new research reports on 16 major stocks, including Boston Scientific Corporation (BSX), Arista Networks, Inc. (ANET)…
Cardiovascular diseases remain the leading global cause of death, taking an estimated 17.9 million lives annually, based on data from…
Boston Scientific pipeline strength fuels quarterly earnings beat…
Barring Neuromodulation, organic and operational revenues at Boston Scientifics (BSX) core business segments rise in the first quarter.…
…
New York (www.aktiencheck.de) - Stryker-Aktienanalyse von Evercore ISI:
Die Analysten von Evercore ISI stufen die Aktie von Stryker Corp. (ISIN: US8636671013,…
Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan…